Alabama Appellate Watch

In Ex parte Novartis Pharmaceutical Corp., the Alabama Supreme Court unanimously ruled that the State's claims against 73 pharmaceutical companies must be severed.  The State sued, in one action,  the 73 companies alleging overcharges to the Alabama Medicaid Agency.  The Supreme Court granted the companies' petition for writ of mandamus and held that the cases did not arise from the same transaction or series of transactions, and thus must be severed.  Click here for the AP report on this decision.